Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Decibel Therapeutics (DBTX)
NASDAQ:DBTX
Holding DBTX?
Track your performance easily
DBTX Stock Chart & Stats
Day’s Range$4.9 - $5.11
52-Week Range― - ―
Previous Close$4.95
Volume1.26M
Average Volume (3M)N/A
Market Cap
$123.37M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$5.25Price Target Upside6.92% Upside
Rating ConsensusHold
Number of Analyst Covering3
Decibel Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DBTX FAQ
What was Decibel Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Decibel Therapeutics’s market cap?
Currently, no data Available
When is Decibel Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Decibel Therapeutics’s earnings last quarter?
Currently, no data Available
Is Decibel Therapeutics overvalued?
According to Wall Street analysts Decibel Therapeutics’s price is currently Undervalued.
Does Decibel Therapeutics pay dividends?
Decibel Therapeutics does not currently pay dividends.
What is Decibel Therapeutics’s EPS estimate?
Decibel Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Decibel Therapeutics have?
Currently, no data Available
What happened to Decibel Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Decibel Therapeutics?
Among the largest hedge funds holding Decibel Therapeutics’s share is Woodline Partners LP. It holds Decibel Therapeutics’s shares valued at N/A.
---
Decibel Therapeutics Stock Smart Score
Company Description
Decibel Therapeutics
Decibel Therapeutics Inc is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders. It aims to restore and improve hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear.
---
DBTX Stock 12 Month Forecast
Average Price Target
$5.25
▲(6.92% Upside)
Best Analysts Covering DBTX
1 Year
1 Year Success Rate
3/5 ratings generated profit
1 Year Average Return
+2.26%
reiterated a buy rating 2 years ago
Copying Neena Bitritto-Garg's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +2.26% per trade.
---